Summit Therapeutics SMMT Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValue.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding?
- Summit Therapeutics (SMMT) reported preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding of $0 in Q1 2026.